SCHEMBL23866609

SCHEMBL23866609

CC(C)NC(=O)[C@@H](C)N1CCC(O)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
PABPC1 P11940 1/20 0.40
APOBEC3A P31941 1/20 0.40
EIF4H Q15056 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
SIGMAR1 Q99720 3/20 0.39
ATM Q13315 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.36
NPSR1 Q6W5P4 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 1/20 0.35
HTT P42858 1/20 0.35
TSHR P16473 1/20 0.34
NPC1 O15118 1/20 0.34
PREP P48147 1/20 0.33
FAP Q12884 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19000029 1.00 KDM4E (0.42) KDM4EPABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL23866597 1.00 KDM4E (0.42) KDM4EPABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL19010252 0.83 KDM4E (0.40) KDM4ESIGMAR1ATMMEN1KMT2A
SCHEMBL27410749 0.83 KDM4E (0.40) KDM4ESIGMAR1ATMMEN1KMT2A
SCHEMBL27410751 0.83 KDM4E (0.40) KDM4ESIGMAR1ATMMEN1KMT2A
SCHEMBL21676255 0.82 CASP6 (0.42) KDM4ESIGMAR1MEN1KMT2ASMN1; SMN2
SCHEMBL23835774 0.82 ATM (0.50) KDM4EPABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL19000013 0.81 PABPC1 (0.36) KDM4EPABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL2553398 0.81 SIGMAR1 (0.40) KDM4EPABPC1APOBEC3AEIF4HAPOBEC3G
SCHEMBL19022016 0.79 SIGMAR1 (0.43) KDM4ESIGMAR1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300940-A1 TLR7/8 ANTAGONISTS AND USES THEREOF MERCK PATENT GMBH (DE) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300940-A1 TLR7/8 ANTAGONISTS AND USES THEREOF TLR7, TLR8, TLR9 KDM4E 1906/4885PABPC1 3076/4885APOBEC3A 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.